Sep 13, 2023 / 01:40PM GMT
Jeffrey D. Johnson - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
All right. Good morning. Why don't we get started? My name is Jeff Johnson. I'm the senior medical technology analyst at Baird. Our next presentation this morning is from DexCom, a leader in the $8 billion global continuous glucose monitoring market.
With us today from DexCom. We're happy to have VP of Investor Relations, Sean Christensen. And Sean, I know the rest of the team is on an executive off-site or something this week. So thanks for making the trip and doing us a solid here and still coming, so thanks for that. I'll turn it over to you if you have a few minutes of any prepared remarks you'd like to make, and then we'll move right into Q&A.
Sean Christensen - DexCom, Inc. - Director of Corporate Affairs & Head of IR
Yes, I'll just start off really quick and Jeff, thanks for hosting us today. We're thrilled to be here. It's an incredibly exciting year for DexCom and obviously for the industry. So we are in the midst of the launch of
Dexcom Inc at Robert W Baird Global Healthcare Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers